Susquehanna International Group’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$150K Sell
61,980
-154,343
-71% -$421K ﹤0.01% 12003
2025
Q4
$943K Buy
216,323
+163,940
+313% +$886K ﹤0.01% 7326
2025
Q3
$220K Buy
+52,383
New +$186K ﹤0.01% 10788
2025
Q2
Sell
-157,331
Closed -$416K 13040
2025
Q1
$425K Buy
+157,331
New +$590K ﹤0.01% 9270
2024
Q4
Sell
-41,432
Closed -$98.2K 12586
2024
Q3
$98.2K Sell
41,432
-32,426
-44% -$71.4K ﹤0.01% 11063
2024
Q2
$144K Buy
+73,858
New +$251K ﹤0.01% 10732

Other funds holding GNLX

Susquehanna International Group's GNLX Position: Q1 2026 in Review

Susquehanna International Group reduced its Genelux (GNLX) stake by 71% in Q1 2026, selling an estimated $421K and leaving 61,980 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #12003.

Susquehanna International Group first reported a position in GNLX in Q2 2024 and has held it in 6 quarters since. The position peaked at $943K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Susquehanna International Group held 61,980 shares of Genelux worth $150K as of Q1 2026.
  • Susquehanna International Group sold 154,343 Genelux shares in Q1 2026, an estimated $421K.
  • Genelux made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12003 holding.
  • Susquehanna International Group first reported a position in Genelux in Q2 2024 and has held it in 6 quarters since.
  • Susquehanna International Group's Genelux position peaked at $943K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.